NYAPRS Note: The following comes from recovery pioneer Pat Deegan. It includes the attached study from Columbia University that identified “the high risk of mortality associated with schizophrenia spectrum diagnoses, ranking second behind age in strength of an association among all demographic and medical risk factors examined in this sample. Individuals with schizophrenia spectrum diagnoses had 2.7 times the odds of dying after adjustment for known risk factors.”
Accordingly, Pat urges people to use the attached COVID-19 Vaccine Decision Making Tool (attached and below).
